Related Experiment Video
Updated: Jun 9, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
let-7 and miR-17-92: small-sized major players in lung cancer development
Hirotaka Osada1, Takashi Takahashi
1Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Abstract:
MicroRNA (miRNA)-encoding small non-coding RNA have been recognized as important regulators of a number of biological processes that inhibit the expression of hundreds of genes. Accumulating evidence also indicates the involvement of miRNA alterations in various types of human cancer, including lung cancer, which has long been the leading cause of cancer death in economically well-developed countries, including Japan. We previously found that downregulation of members of the tumor-suppressive let-7 miRNA family and overexpression of the oncogenic miR-17-92 miRNA cluster frequently occur in lung cancers, and molecular insight into how these miRNA alterations may contribute to tumor development has been rapidly accumulating. The present review summarizes recent advances in elucidation of the molecular functions of these miRNA in relation to their roles in the pathogenesis of lung cancer. Given the crucial roles of miRNA alterations, additional studies are expected to provide a better understanding of the underlying molecular mechanisms of disease development, as well as a foundation for novel strategies for cancer diagnosis and treatment of this devastating disease.
Insights
MicroRNA (miRNA) alterations are implicated in lung cancer development. This review details how specific miRNA changes contribute to lung cancer pathogenesis, offering insights for future diagnostics and treatments.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- miRNA alterations are linked to human cancers, particularly lung cancer.
- Specific miRNA dysregulations, like let-7 family downregulation and miR-17-92 cluster overexpression, are common in lung cancer.
Purpose of the Study:
- To review recent advances in understanding miRNA molecular functions.
- To elucidate the role of miRNA alterations in lung cancer pathogenesis.
- To highlight the potential of miRNAs in cancer diagnosis and treatment.
Main Methods:
- Literature review of recent studies on miRNA functions in lung cancer.
- Analysis of molecular mechanisms underlying miRNA involvement in tumorigenesis.
- Synthesis of current knowledge on miRNA alterations in lung cancer.
Main Results:
- miRNA alterations significantly impact biological processes and gene expression.
- Downregulation of tumor-suppressive let-7 miRNAs and overexpression of oncogenic miR-17-92 are frequent in lung cancer.
- Molecular insights into miRNA roles in lung cancer development are rapidly accumulating.
Conclusions:
- miRNA alterations are crucial in lung cancer pathogenesis.
- Further research on miRNA mechanisms will enhance understanding of lung cancer development.
- miRNAs hold promise for novel strategies in lung cancer diagnosis and therapy.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
